Biocept logo

Biocept BIOC

$ 0.43 -13.05%

Quarterly report 2023-Q2
added 08-14-2023

report update icon

Country

usaUSA

IPO year

2014

Industry

Diagnostics research

Stock Exchange

NASDAQ CAPITAL

CEO

Mr. Michael Nall

Employees in the company

88

Shares

17 M

Market Cap[1]

$ 7.29 M

EBITDA (LTM)

$ -21.8 M

P/E (LTM)

-0.05

P/S (LTM)

1.47

EPS (LTM)

-22.06

Other stocks of industry "Diagnostics research"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.